Carisma Therapeutics Inc.
CEO, Board Member
2026-01-01–present
CEO
Carisma Therapeutics Inc.
Carisma Therapeutics Inc.
Board Member
Carisma Therapeutics Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Craig R. Jalbert is recorded as CEO and Board Member at Carisma Therapeutics Inc.. Carisma Therapeutics Inc. reported in an 8-K filed December 5, 2025 that Craig R. Jalbert was appointed director, effective January 1, 2026. Carisma Therapeutics Inc. reported in an 8-K filed December 5, 2025 that Craig R. Jalbert was appointed Chief Executive Officer, effective January 1, 2026. Carisma Therapeutics Inc. reported in an 8-K filed December 5, 2025 that Craig R. Jalbert was appointed President, Treasurer and Secretary, effective January 1, 2026.
“On December 4, 2025, the Board also appointed Mr. Jalbert as a director, effective as of January 1, 2026.”
“On December 4, 2025, the Board appointed Craig R. Jalbert to serve as the Chief Executive Officer, President, Treasurer and Secretary of the Company, effective as of January 1, 2026, to succeed Mr. Kelly and to assist with the Company's remaining wind down activities.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Carisma Therapeutics Inc.
CEO
SEC 8-K
2026-01-01–present
Carisma Therapeutics Inc.
SEC 8-K
2026-01-01–present
Carisma Therapeutics Inc.
Board Member
SEC 8-K
2026-01-01–present
Recorded roles and call appearances connecting this person to public companies.
Carisma Therapeutics Inc.
CEO, Board Member
2026-01-01–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.